Overview

Topical CP-690,550 For Chronic Plaque Psoriasis

Status:
Completed

Trial end date:
2009-07-24

Target enrollment:

Participant gender:

Summary

Study will test effectiveness of an experimental drug applied once or twice daily to two psoriasis plaques. Requires 1 clinic visit each week for 5 weeks.

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Tofacitinib